-
-
-
-
-
-
-
BioCardia receives FDA guidance on two approval pathways for Helix catheter
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on BioCardiAa (BCDA)
-
-
-
-
-
-
-
BioCardia (BCDA) Misses Q1 EPS by 59c
-
-
-
-
-
-
-
BioCardia (BCDA) Announces Positive Consultation with Japan PMDA on CardiAMP Cell Therapy
-
-
-
-
-
-
-
BioCardiAa (BCDA) PT Raised to $25 at H.C. Wainwright
-
-
-
456,379 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

